TABLE 2.
Baseline and treatment characteristics for patients with meningioma. (n = 2070)
Variable |
Meningioma patients (n = 2070) |
---|---|
Age, median (First quartile(Q1), Third quartile(Q3)) | 60 (49, 69) |
Female, n (%) | 1449, (70.0) |
Asymptomatic, n (%) | 294 (14.2) |
WHO functional status, n (%) | |
0, fully active | 933 (45.1) |
1, light work possible | 566 (27.3) |
2, cares for self | 305 (14.7) |
3, limited self care | 144 (7.0) |
4, disabled, confined to bed | 20 (1.0) |
Missing | 102 |
Tumor laterality, n (%) | |
Left | 736 (35.6) |
Right | 856 (41.4) |
Bilateral | 123 (5.9) |
Missing | 355 |
Localization, n (%) | |
Skull‐base | 290 (14.0) |
Not Skull‐base | 1780 (86.0) |
Tumor size, n (%) | |
<4 cm | 924 (52.8) |
4–6 cm | 597 (34.1) |
>6 cm | 230 (13.1) |
Missing | 319 |
Simpson grade, n (%) | |
Grade I‐III | 1587 (86.5) |
Grade IV‐V | 247 (13.5) |
Missing | 236 |
New deficit after surgery, n (%) | 310 (15.0) |
Missing | 4 |
Reoperation due to complication, n (%) | 103 (5.0) |
Missing | 3 |
WHO grade, n (%) | |
Grade I | 1803 (87.1) |
Grade II‐III | 267 (12.9) |
Oncological treatment planned, n (%) | 120 (5.9) |
Missing | 27 |
Wait time from radiological diagnosis (surgery date‐radiological diagnosis), weeks median (Q1,Q3) | 10 (4, 24) |